Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

NeoGenomics, Inc. (NEO) had Revenue of $186.67M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$186.67M
Net Income	$-17.11M
Cost of Goods Sold	$105.81M
Gross Profit	$80.86M
Operating Expenses	$204.91M
Operating Income	$-18.24M
Non-Operating Income/Expense	$0.66M
Pre-Tax Income	$-17.58M
Normalized Pre-Tax Income	$-17.58M
Income after Taxes	$-17.11M
Income from Continuous Operations	$-17.11M
Consolidated Net Income/Loss	$-17.11M
Normalized Income after Taxes	$-17.11M
EBIT	$-18.24M
EBITDA	$-1.83M
Weighted-Average Shares Outstanding (Basic)	129.17M
Weighted-Average Shares Outstanding (Diluted)	129.17M
Earnings per Share (EPS) (Basic)	$-0.13
Earnings per Share (EPS) (Diluted)	$-0.13
Balance Sheet Financials
Current Assets	$373.68M
Property, Plant, and Equipment	$83.66M
Long-Term Assets	$972.85M
Total Assets	$1.35B
Current Liabilities	$84.59M
Long-Term Debt	$342.24M
Long-Term Liabilities	$433.18M
Total Liabilities	$517.77M
Common Equity	$828.76M
Tangible Shareholders Equity	$25.87M
Shareholders Equity	$828.76M
Common Shares Outstanding	129.65M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-8.14M
Cash Flow from Investing Activities	$-5.00M
Cash Flow from Financial Activities	$-0.34M
Beginning Cash	$159.62M
End Cash	$146.14M
Increase/Decrease in Cash	$-13.47M
Stock-Based Compensation	$9.64M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.42
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.29
Debt to Equity Ratio	0.42
Gross Margin	43.32%
Operating Margin	-9.77%
EBIT Margin	-9.77%
EBITDA Margin	--
Pre-Tax Profit Margin	-9.42%
Profit Margin	-9.16%
Free Cash Flow	$-13.14M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	3.55
Receiveable Turnover	1.11
Days Sales in Receivables	80.72
Return on Equity	-2.06%
Return on Tangible Equity	-66.12%
Return on Assets	-1.27%
Return on Investments	-1.46%
Book Value Per Share	$6.39
Free Cash Flow per Share	$-0.10
Operating Cash Flow per Share	$-0.06

Data from Zacks Investment Research, Inc.